Explore how proteomics supports pre-symptomatic disease detection, from mass spectrometry advances to multi-omics models and clinical validation challenges.

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...

A new study suggests that artificial intelligence, also known as AI, may offer a better solution. Scientists have developed a ...

GPT-5.4 is out now on ChatGPT (where it goes by the name GPT-5.4 Thinking) as well as on the OpenAI API and OpenAI’s coding ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

Scientists have developed an AI system that analyzes complex gene-expression signatures to estimate the likelihood that a tumor will spread.

Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a result, patients with T1D must closely monitor their blood glucose (BG) ...

OpenAI's new GPT-5.4 clobbers humans on pro-level work in tests - by 83% ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Pressure is mounting publicly and privately for entertainment mogul Casey Wasserman to step down as chair of the 2028 Los Angeles Olympics following a series of embarrassing and salacious emails with ...